Tag: lung cancer surgery market insights

Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.

Lung Cancer Surgery Market CAGR Analysis And Future Market Development

The market for lung cancer surgeries has experienced robust expansion over the past few years, and this upward trajectory is projected to continue. Specifically, the market is anticipated to increase from $5.33 billion in 2025 to $5.6 billion in 2026, reflecting a compound annual growth rate of 5.1%. This historical growth can be attributed to several key factors, including a rise in the incidence of lung cancer, enhancement of surgical capacities within healthcare facilities, a sufficient supply of skilled thoracic surgeons, the increasing utilization of minimally invasive video-assisted thoracoscopic surgery techniques, and heightened public awareness regarding the benefits of early-stage lung cancer treatment.

The market for lung cancer surgical procedures is projected for consistent expansion over the upcoming years, with an anticipated valuation of $6.73 billion by 2030. This growth trajectory is underpinned by a compound annual growth rate (CAGR) of 4.7%, driven by several key factors: the increasing integration of robotic surgical systems, a heightened demand for precise surgical results, the proliferation of specialized cancer treatment facilities, escalating investments in surgical technology, and the broader adoption of enhanced recovery protocols following surgery. During this projected period, prominent trends are expected to shape the market, including a greater emphasis on minimally invasive surgical approaches, a rise in robotic-assisted thoracic surgeries, a preference for surgical methods that preserve lung function, expanded utilization of advanced surgical instruments, and a heightened concentration on optimizing outcomes in the period after surgery.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25816&type=smp

Lung Cancer Surgery Market Growth Factors Supporting Long-Term Expansion

An observable surge in lung cancer cases is anticipated to drive the expansion of the lung cancer surgery market. This condition, characterized by the unchecked proliferation of aberrant cells within the lungs, impairs their regular operation. Factors contributing to the rising prevalence of lung cancer include extended exposure to environmental pollutants, particularly fine particulate matter (PM2.5). These minuscule particles are capable of reaching deep within the pulmonary tissues, triggering inflammation, cellular harm, and genetic alterations that can initiate the development of cancer. Lung cancer surgery plays a crucial role in mitigating mortality rates associated with the disease by facilitating the prompt excision of cancerous growths before they metastasize or advance. Illustratively, data from the Centers for Disease Control and Prevention indicate that in 2023, lung cancer accounted for 131,584 fatalities in the United States, subsequent to 218,893 new diagnoses in 2022. Consequently, the escalating rates of lung cancer are acting as a catalyst for the growth of the lung cancer surgery market.

Lung Cancer Surgery Market Segment Analysis And Revenue Opportunities

The lung cancer surgery market covered in this report is segmented –

1) By Surgical Approach: Thoracotomy, Minimally Invasive Surgeries

2) By Procedure: Lobectomy, Segmentectomy, Pneumonectomy, Sleeve Resection, Extended Reserction

3) By Product: Thoracoscopes, Mediastinoscopes, Bronchoscopes, Robotic-Assistes Thoracic Surgery Systems, Surgical Staplers, Surgical Energy Instruments, Advanced Energy Instruments, Advanced Bipolar Instruments, Ultrasonic Instruments

4) By Distribution Channels: Direct Tender, Retail Sales, Online Sales, Other Channels

5) By End User: Hospitals, Ambulatory And Surgical Centres, Academic And Research Institutes, Specialiaty Cancer Care Centre, Other End Users

Subsegments:

1) By Thoracotomy: Lobectomy, Pneumonectomy, Segmentectomy, Wedge Resection

2) By Minimally Invasive Surgeries: Video-Assisted Thoracoscopic Surgery (VATS), Robotic-Assisted Surgery

Lung Cancer Surgery Market Industry Trends Shaping Future Revenue Growth

Leading entities within the lung cancer surgery sector are directing their efforts toward pioneering advancements, with robotic-assisted procedures being a key area of focus aimed at elevating surgical accuracy, accelerating patient recuperation periods, and ultimately achieving superior health results. Robotic-assisted surgery encompasses less invasive operations executed with the aid of robotic equipment, which surgeons skillfully operate to boost exactness, lessen adverse events, and foster better patient recovery. A prime illustration of this trend occurred in March 2025 when Johnson & Johnson MedTech, a prominent American innovator in medical equipment and technology, revealed that its MONARCH QUEST system had secured regulatory approval via the U.S. 510(k) pathway. This MONARCH QUEST robotic-assisted bronchoscopy system is engineered to provide superior reach and stability, enabling access to minuscule and challenging-to-reach lung nodules, thereby facilitating the earlier detection of lung cancer. Furthermore, its sophisticated maneuverability, coupled with seamless integration with imaging systems, permits more precise tissue sampling with diminished patient discomfort. The system’s design is intended to broaden the scope of usable procedures and optimize operational efficiency, consequently promoting increased clinical assurance and uniformity throughout a diverse array of bronchoscopic interventions.

Lung Cancer Surgery Market Leading Players Shaping Industry Direction

Major companies operating in the lung cancer surgery market are Johnson And Johnson, Medtronic plc, Fujifilm Holdings Corporation, B Braun Melsungen AG, Olympus Corporation, Intuitive Surgical Inc, Teleflex Incorporated, Karl Storz SE, Lepu Medical Technology Beijing Co Ltd, Ambu AS, KLS Martin Group, Richard Wolf GmbH, Ethicon Inc, Ackermann Instrument GmbH, Scanlan International Inc, Sontec Instruments Inc, Covidien LLC, Stryker Corporation, Smith And Nephew plc, CONMED Corporation, Erbe Elektromedizin GmbH

Access The Complete Lung Cancer Surgery Market Report:

https://www.thebusinessresearchcompany.com/report/lung-cancer-surgery-global-market-report

Lung Cancer Surgery Market Largest Region By Revenue And Market Share

North Americawas the largest region in the lung cancer surgery market in 2025. Asia-Pacificis expected to be the fastest-growing region in the forecast period. The regions covered in the lung cancer surgery market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.

Lung Cancer Surgery Market CAGR Analysis And Future Market Development

The market for lung cancer surgeries has experienced robust expansion over the past few years, and this upward trajectory is projected to continue. Specifically, the market is anticipated to increase from $5.33 billion in 2025 to $5.6 billion in 2026, reflecting a compound annual growth rate of 5.1%. This historical growth can be attributed to several key factors, including a rise in the incidence of lung cancer, enhancement of surgical capacities within healthcare facilities, a sufficient supply of skilled thoracic surgeons, the increasing utilization of minimally invasive video-assisted thoracoscopic surgery techniques, and heightened public awareness regarding the benefits of early-stage lung cancer treatment.

The market for lung cancer surgical procedures is projected for consistent expansion over the upcoming years, with an anticipated valuation of $6.73 billion by 2030. This growth trajectory is underpinned by a compound annual growth rate (CAGR) of 4.7%, driven by several key factors: the increasing integration of robotic surgical systems, a heightened demand for precise surgical results, the proliferation of specialized cancer treatment facilities, escalating investments in surgical technology, and the broader adoption of enhanced recovery protocols following surgery. During this projected period, prominent trends are expected to shape the market, including a greater emphasis on minimally invasive surgical approaches, a rise in robotic-assisted thoracic surgeries, a preference for surgical methods that preserve lung function, expanded utilization of advanced surgical instruments, and a heightened concentration on optimizing outcomes in the period after surgery.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25816&type=smp

Lung Cancer Surgery Market Growth Factors Supporting Long-Term Expansion

An observable surge in lung cancer cases is anticipated to drive the expansion of the lung cancer surgery market. This condition, characterized by the unchecked proliferation of aberrant cells within the lungs, impairs their regular operation. Factors contributing to the rising prevalence of lung cancer include extended exposure to environmental pollutants, particularly fine particulate matter (PM2.5). These minuscule particles are capable of reaching deep within the pulmonary tissues, triggering inflammation, cellular harm, and genetic alterations that can initiate the development of cancer. Lung cancer surgery plays a crucial role in mitigating mortality rates associated with the disease by facilitating the prompt excision of cancerous growths before they metastasize or advance. Illustratively, data from the Centers for Disease Control and Prevention indicate that in 2023, lung cancer accounted for 131,584 fatalities in the United States, subsequent to 218,893 new diagnoses in 2022. Consequently, the escalating rates of lung cancer are acting as a catalyst for the growth of the lung cancer surgery market.

Lung Cancer Surgery Market Segment Analysis And Revenue Opportunities

The lung cancer surgery market covered in this report is segmented –

1) By Surgical Approach: Thoracotomy, Minimally Invasive Surgeries

2) By Procedure: Lobectomy, Segmentectomy, Pneumonectomy, Sleeve Resection, Extended Reserction

3) By Product: Thoracoscopes, Mediastinoscopes, Bronchoscopes, Robotic-Assistes Thoracic Surgery Systems, Surgical Staplers, Surgical Energy Instruments, Advanced Energy Instruments, Advanced Bipolar Instruments, Ultrasonic Instruments

4) By Distribution Channels: Direct Tender, Retail Sales, Online Sales, Other Channels

5) By End User: Hospitals, Ambulatory And Surgical Centres, Academic And Research Institutes, Specialiaty Cancer Care Centre, Other End Users

Subsegments:

1) By Thoracotomy: Lobectomy, Pneumonectomy, Segmentectomy, Wedge Resection

2) By Minimally Invasive Surgeries: Video-Assisted Thoracoscopic Surgery (VATS), Robotic-Assisted Surgery

Lung Cancer Surgery Market Industry Trends Shaping Future Revenue Growth

Leading entities within the lung cancer surgery sector are directing their efforts toward pioneering advancements, with robotic-assisted procedures being a key area of focus aimed at elevating surgical accuracy, accelerating patient recuperation periods, and ultimately achieving superior health results. Robotic-assisted surgery encompasses less invasive operations executed with the aid of robotic equipment, which surgeons skillfully operate to boost exactness, lessen adverse events, and foster better patient recovery. A prime illustration of this trend occurred in March 2025 when Johnson & Johnson MedTech, a prominent American innovator in medical equipment and technology, revealed that its MONARCH QUEST system had secured regulatory approval via the U.S. 510(k) pathway. This MONARCH QUEST robotic-assisted bronchoscopy system is engineered to provide superior reach and stability, enabling access to minuscule and challenging-to-reach lung nodules, thereby facilitating the earlier detection of lung cancer. Furthermore, its sophisticated maneuverability, coupled with seamless integration with imaging systems, permits more precise tissue sampling with diminished patient discomfort. The system’s design is intended to broaden the scope of usable procedures and optimize operational efficiency, consequently promoting increased clinical assurance and uniformity throughout a diverse array of bronchoscopic interventions.

Lung Cancer Surgery Market Leading Players Shaping Industry Direction

Major companies operating in the lung cancer surgery market are Johnson And Johnson, Medtronic plc, Fujifilm Holdings Corporation, B Braun Melsungen AG, Olympus Corporation, Intuitive Surgical Inc, Teleflex Incorporated, Karl Storz SE, Lepu Medical Technology Beijing Co Ltd, Ambu AS, KLS Martin Group, Richard Wolf GmbH, Ethicon Inc, Ackermann Instrument GmbH, Scanlan International Inc, Sontec Instruments Inc, Covidien LLC, Stryker Corporation, Smith And Nephew plc, CONMED Corporation, Erbe Elektromedizin GmbH

Access The Complete Lung Cancer Surgery Market Report:

https://www.thebusinessresearchcompany.com/report/lung-cancer-surgery-global-market-report

Lung Cancer Surgery Market Largest Region By Revenue And Market Share

North Americawas the largest region in the lung cancer surgery market in 2025. Asia-Pacificis expected to be the fastest-growing region in the forecast period. The regions covered in the lung cancer surgery market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.

Lung Cancer Surgery Market CAGR Analysis And Future Market Development

The market for lung cancer surgeries has experienced robust expansion over the past few years, and this upward trajectory is projected to continue. Specifically, the market is anticipated to increase from $5.33 billion in 2025 to $5.6 billion in 2026, reflecting a compound annual growth rate of 5.1%. This historical growth can be attributed to several key factors, including a rise in the incidence of lung cancer, enhancement of surgical capacities within healthcare facilities, a sufficient supply of skilled thoracic surgeons, the increasing utilization of minimally invasive video-assisted thoracoscopic surgery techniques, and heightened public awareness regarding the benefits of early-stage lung cancer treatment.

The market for lung cancer surgical procedures is projected for consistent expansion over the upcoming years, with an anticipated valuation of $6.73 billion by 2030. This growth trajectory is underpinned by a compound annual growth rate (CAGR) of 4.7%, driven by several key factors: the increasing integration of robotic surgical systems, a heightened demand for precise surgical results, the proliferation of specialized cancer treatment facilities, escalating investments in surgical technology, and the broader adoption of enhanced recovery protocols following surgery. During this projected period, prominent trends are expected to shape the market, including a greater emphasis on minimally invasive surgical approaches, a rise in robotic-assisted thoracic surgeries, a preference for surgical methods that preserve lung function, expanded utilization of advanced surgical instruments, and a heightened concentration on optimizing outcomes in the period after surgery.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25816&type=smp

Lung Cancer Surgery Market Growth Factors Supporting Long-Term Expansion

An observable surge in lung cancer cases is anticipated to drive the expansion of the lung cancer surgery market. This condition, characterized by the unchecked proliferation of aberrant cells within the lungs, impairs their regular operation. Factors contributing to the rising prevalence of lung cancer include extended exposure to environmental pollutants, particularly fine particulate matter (PM2.5). These minuscule particles are capable of reaching deep within the pulmonary tissues, triggering inflammation, cellular harm, and genetic alterations that can initiate the development of cancer. Lung cancer surgery plays a crucial role in mitigating mortality rates associated with the disease by facilitating the prompt excision of cancerous growths before they metastasize or advance. Illustratively, data from the Centers for Disease Control and Prevention indicate that in 2023, lung cancer accounted for 131,584 fatalities in the United States, subsequent to 218,893 new diagnoses in 2022. Consequently, the escalating rates of lung cancer are acting as a catalyst for the growth of the lung cancer surgery market.

Lung Cancer Surgery Market Segment Analysis And Revenue Opportunities

The lung cancer surgery market covered in this report is segmented –

1) By Surgical Approach: Thoracotomy, Minimally Invasive Surgeries

2) By Procedure: Lobectomy, Segmentectomy, Pneumonectomy, Sleeve Resection, Extended Reserction

3) By Product: Thoracoscopes, Mediastinoscopes, Bronchoscopes, Robotic-Assistes Thoracic Surgery Systems, Surgical Staplers, Surgical Energy Instruments, Advanced Energy Instruments, Advanced Bipolar Instruments, Ultrasonic Instruments

4) By Distribution Channels: Direct Tender, Retail Sales, Online Sales, Other Channels

5) By End User: Hospitals, Ambulatory And Surgical Centres, Academic And Research Institutes, Specialiaty Cancer Care Centre, Other End Users

Subsegments:

1) By Thoracotomy: Lobectomy, Pneumonectomy, Segmentectomy, Wedge Resection

2) By Minimally Invasive Surgeries: Video-Assisted Thoracoscopic Surgery (VATS), Robotic-Assisted Surgery

Lung Cancer Surgery Market Industry Trends Shaping Future Revenue Growth

Leading entities within the lung cancer surgery sector are directing their efforts toward pioneering advancements, with robotic-assisted procedures being a key area of focus aimed at elevating surgical accuracy, accelerating patient recuperation periods, and ultimately achieving superior health results. Robotic-assisted surgery encompasses less invasive operations executed with the aid of robotic equipment, which surgeons skillfully operate to boost exactness, lessen adverse events, and foster better patient recovery. A prime illustration of this trend occurred in March 2025 when Johnson & Johnson MedTech, a prominent American innovator in medical equipment and technology, revealed that its MONARCH QUEST system had secured regulatory approval via the U.S. 510(k) pathway. This MONARCH QUEST robotic-assisted bronchoscopy system is engineered to provide superior reach and stability, enabling access to minuscule and challenging-to-reach lung nodules, thereby facilitating the earlier detection of lung cancer. Furthermore, its sophisticated maneuverability, coupled with seamless integration with imaging systems, permits more precise tissue sampling with diminished patient discomfort. The system’s design is intended to broaden the scope of usable procedures and optimize operational efficiency, consequently promoting increased clinical assurance and uniformity throughout a diverse array of bronchoscopic interventions.

Lung Cancer Surgery Market Leading Players Shaping Industry Direction

Major companies operating in the lung cancer surgery market are Johnson And Johnson, Medtronic plc, Fujifilm Holdings Corporation, B Braun Melsungen AG, Olympus Corporation, Intuitive Surgical Inc, Teleflex Incorporated, Karl Storz SE, Lepu Medical Technology Beijing Co Ltd, Ambu AS, KLS Martin Group, Richard Wolf GmbH, Ethicon Inc, Ackermann Instrument GmbH, Scanlan International Inc, Sontec Instruments Inc, Covidien LLC, Stryker Corporation, Smith And Nephew plc, CONMED Corporation, Erbe Elektromedizin GmbH

Access The Complete Lung Cancer Surgery Market Report:

https://www.thebusinessresearchcompany.com/report/lung-cancer-surgery-global-market-report

Lung Cancer Surgery Market Largest Region By Revenue And Market Share

North Americawas the largest region in the lung cancer surgery market in 2025. Asia-Pacificis expected to be the fastest-growing region in the forecast period. The regions covered in the lung cancer surgery market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Is The Market Value Of The Lung Cancer Surgery Market Projected To Expand During 2026–2030?

The lung cancer surgery market size has experienced significant expansion over recent years. It is anticipated to grow from $5.33 billion in 2025 to $5.6 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 5.1%. The increase observed in the past can be credited to rising lung cancer incidence rates, the expansion of surgical capacities in hospitals, the availability of proficient thoracic surgeons, the increasing use of video-assisted thoracoscopic surgery, and enhanced awareness regarding early-stage lung cancer treatment.

The lung cancer surgery market is anticipated to experience consistent expansion in the coming years. It is projected to achieve a value of $6.73 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 4.7%. This growth over the forecast period can be attributed to the increasing integration of robotic surgery platforms, a rising demand for precise surgical outcomes, the expansion of specialized cancer care centers, growing investments in surgical technology, and the increasing adoption of enhanced recovery after surgery protocols. Major trends during this period include a greater uptake of minimally invasive surgical techniques, the rising use of robotic-assisted thoracic surgery, a growing preference for lung-preserving procedures, an expansion in the utilization of advanced surgical instruments, and an enhanced focus on post-surgical recovery outcomes.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25816&type=smp

What Are The Main Drivers Accelerating The Growth Of The Lung Cancer Surgery Market?

The rising occurrence of lung cancer is projected to drive the expansion of the lung cancer surgery market in the future. This condition involves the unchecked multiplication of atypical cells within one or both lungs, potentially disrupting their regular operation. This escalating prevalence of lung cancer stems from extended exposure to air pollution, particularly fine particulate matter. Such microscopic particles are capable of reaching deep into the lungs, triggering inflammation, harming cells, and inducing genetic changes that may result in cancer formation. Surgical intervention for lung cancer contributes to lowering the mortality rate associated with the disease by facilitating the prompt excision of cancerous tumors before their potential dissemination or advancement. As an illustration, in June 2025, data from the Centers for Disease Control and Prevention, a US-based federal government agency, indicated that in 2023, lung cancer caused 131,584 deaths in the United States, subsequent to 218,893 newly reported cases in 2022. Consequently, the increasing incidence of lung cancer is stimulating the expansion of the lung cancer surgery market.

How Is The Lung Cancer Surgery Market Structured Across Different Market Segments?

The lung cancer surgery market covered in this report is segmented –

1) By Surgical Approach: Thoracotomy, Minimally Invasive Surgeries

2) By Procedure: Lobectomy, Segmentectomy, Pneumonectomy, Sleeve Resection, Extended Reserction

3) By Product: Thoracoscopes, Mediastinoscopes, Bronchoscopes, Robotic-Assistes Thoracic Surgery Systems, Surgical Staplers, Surgical Energy Instruments, Advanced Energy Instruments, Advanced Bipolar Instruments, Ultrasonic Instruments

4) By Distribution Channels: Direct Tender, Retail Sales, Online Sales, Other Channels

5) By End User: Hospitals, Ambulatory And Surgical Centres, Academic And Research Institutes, Specialiaty Cancer Care Centre, Other End Users

Subsegments:

1) By Thoracotomy: Lobectomy, Pneumonectomy, Segmentectomy, Wedge Resection

2) By Minimally Invasive Surgeries: Video-Assisted Thoracoscopic Surgery (VATS), Robotic-Assisted Surgery

What Trends Are Influencing The Future Of The Lung Cancer Surgery Market?

Leading companies in the lung cancer surgery market are prioritizing the development of innovative technologies, such as robotic-assisted surgeries, to improve surgical accuracy, shorten recovery periods, and enhance patient outcomes. Robotic-assisted surgeries are defined as minimally invasive procedures carried out using robotic systems controlled by surgeons, aiming to boost precision, lessen complications, and better patient rehabilitation results. For instance, in March 2025, Johnson & Johnson MedTech, a US-based medical devices and technology company, announced the regulatory clearance of MONARCH QUEST under U.S. 510(k). The MONARCH QUEST robotic-assisted bronchoscopy platform provides superior reach and stability to access small, hard-to-reach lung nodules, thus improving the capability to diagnose lung cancer in its earlier stages. Its advanced maneuverability and integration with imaging technologies facilitate more accurate biopsies while minimizing patient discomfort. Designed to expand procedural capabilities and streamline workflow, the platform supports increased clinical confidence and consistency across a broader array of bronchoscopic procedures.

Which Industry Players Are Present In The Lung Cancer Surgery Market?

Major companies operating in the lung cancer surgery market are Johnson And Johnson, Medtronic plc, Fujifilm Holdings Corporation, B Braun Melsungen AG, Olympus Corporation, Intuitive Surgical Inc, Teleflex Incorporated, Karl Storz SE, Lepu Medical Technology Beijing Co Ltd, Ambu AS, KLS Martin Group, Richard Wolf GmbH, Ethicon Inc, Ackermann Instrument GmbH, Scanlan International Inc, Sontec Instruments Inc, Covidien LLC, Stryker Corporation, Smith And Nephew plc, CONMED Corporation, Erbe Elektromedizin GmbH

Access The Complete Lung Cancer Surgery Market Report:

https://www.thebusinessresearchcompany.com/report/lung-cancer-surgery-global-market-report

Which Region Holds The Largest Share In The Lung Cancer Surgery Market?

North America was the largest region in the lung cancer surgery market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lung cancer surgery market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Lung Cancer Surgery Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=25816&type=smp

Browse Through More Reports Similar to the Global Lung Cancer Surgery Market 2026, By The Business Research Company

Lung Cancer Diagnostic And Screening Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/lung-cancer-diagnostic-and-screening-global-market-report

Non Small Cell Lung Cancer Nsclc Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/non-small-cell-lung-cancer-nsclc-global-market-report

Non Small Cell Lung Cancer Nsclc Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/non-small-cell-lung-cancer-nsclc-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Forecasted Market Size Trajectory Of The Lung Cancer Surgery Market From 2026 To 2030?

The lung cancer surgery market has shown substantial growth recently. It is anticipated to increase from $5.33 billion in 2025 to $5.6 billion in 2026, achieving a compound annual growth rate (CAGR) of 5.1%. This historical expansion can be attributed to several factors, including rising lung cancer incidence rates, improved hospital surgical capabilities, the availability of proficient thoracic surgeons, the increasing adoption of video-assisted thoracoscopic surgery, and enhanced awareness regarding early-stage lung cancer treatment.

The lung cancer surgery market is expected to experience consistent growth over the next few years. It is projected to expand to $6.73 billion by 2030, driven by a compound annual growth rate (CAGR) of 4.7%. This anticipated growth can be attributed to several factors during the forecast period, such as the increasing integration of robotic surgery platforms, a rising demand for precise surgical outcomes, the expansion of specialized cancer care centers, growing investments in surgical technology, and the wider adoption of enhanced recovery after surgery protocols. Major trends identified for this period include the increasing uptake of minimally invasive surgical techniques, a surge in the use of robotic-assisted thoracic surgery, a growing preference for lung-preserving procedures, the broader utilization of advanced surgical instruments, and an enhanced focus on post-surgical recovery outcomes.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25816&type=smp

Which Important Drivers Are Guiding The Lung Cancer Surgery Market Growth?

The rising prevalence of lung cancer is anticipated to drive the expansion of the lung cancer surgery market moving forward. Lung cancer is characterized by the uncontrolled proliferation of abnormal cells within one or both lungs, which can disrupt their normal functioning. This increasing incidence of lung cancer is attributed to prolonged exposure to air pollution, particularly fine particulate matter, as these minute particles can penetrate deeply into lung tissue, leading to inflammation, cellular damage, and genetic mutations that contribute to cancer development. Lung cancer surgery plays a crucial role in reducing deaths related to the disease by enabling the early excision of malignant tumors before they can metastasize or advance. For example, according to the Centers for Disease Control and Prevention, a US-based federal government agency, it was reported in June 2025 that lung cancer was responsible for 131,584 deaths in the United States in 2023, following 218,893 newly reported cases in 2022. Therefore, the escalating occurrence of lung cancer is a primary driver propelling growth in the lung cancer surgery market.

Which Segments Define The Lung Cancer Surgery Market Segment Structure?

The lung cancer surgery market covered in this report is segmented –

1) By Surgical Approach: Thoracotomy, Minimally Invasive Surgeries

2) By Procedure: Lobectomy, Segmentectomy, Pneumonectomy, Sleeve Resection, Extended Reserction

3) By Product: Thoracoscopes, Mediastinoscopes, Bronchoscopes, Robotic-Assistes Thoracic Surgery Systems, Surgical Staplers, Surgical Energy Instruments, Advanced Energy Instruments, Advanced Bipolar Instruments, Ultrasonic Instruments

4) By Distribution Channels: Direct Tender, Retail Sales, Online Sales, Other Channels

5) By End User: Hospitals, Ambulatory And Surgical Centres, Academic And Research Institutes, Specialiaty Cancer Care Centre, Other End Users

Subsegments:

1) By Thoracotomy: Lobectomy, Pneumonectomy, Segmentectomy, Wedge Resection

2) By Minimally Invasive Surgeries: Video-Assisted Thoracoscopic Surgery (VATS), Robotic-Assisted Surgery

What Trends Are Influencing The Evolution Of The Lung Cancer Surgery Market?

Leading companies operating in the lung cancer surgery market are prioritizing the development of innovative technologies, such as robotic-assisted surgeries, to improve surgical precision, shorten recovery times, and enhance patient outcomes. Robotic-assisted surgeries denote minimally invasive procedures performed with robotic systems controlled by surgeons, intended to boost accuracy, lessen complications, and better patient recovery. For instance, in March 2025, Johnson & Johnson MedTech, a US-based medical devices and technology company, announced the regulatory clearance of MONARCH QUEST under U.S. 510(k). The MONARCH QUEST robotic-assisted bronchoscopy platform offers enhanced reach and stability for accessing small, challenging-to-reach lung nodules, consequently improving the capacity for earlier lung cancer diagnosis. Its advanced maneuverability and integration with imaging technologies facilitate more accurate biopsies while minimizing patient discomfort. Designed to expand procedural capabilities and streamline workflow, the platform supports greater clinical confidence and consistency across a wider range of bronchoscopic procedures.

Who Are The Established Players Within The Lung Cancer Surgery Market?

Major companies operating in the lung cancer surgery market are Johnson And Johnson, Medtronic plc, Fujifilm Holdings Corporation, B Braun Melsungen AG, Olympus Corporation, Intuitive Surgical Inc, Teleflex Incorporated, Karl Storz SE, Lepu Medical Technology Beijing Co Ltd, Ambu AS, KLS Martin Group, Richard Wolf GmbH, Ethicon Inc, Ackermann Instrument GmbH, Scanlan International Inc, Sontec Instruments Inc, Covidien LLC, Stryker Corporation, Smith And Nephew plc, CONMED Corporation, Erbe Elektromedizin GmbH

Get The Full Lung Cancer Surgery Market Report:

https://www.thebusinessresearchcompany.com/report/lung-cancer-surgery-global-market-report

Where Is The Lung Cancer Surgery Market Primarily Concentrated By Region?

North America was the largest region in the lung cancer surgery market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lung cancer surgery market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Lung Cancer Surgery Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/lung-cancer-surgery-global-market-report

Browse Through More Reports Similar to the Global Lung Cancer Surgery Market 2026, By The Business Research Company

Lung Cancer Diagnostic And Screening Market Report 2026

https://www.thebusinessresearchcompany.com/report/lung-cancer-diagnostic-and-screening-global-market-report

Non Small Cell Lung Cancer Nsclc Market Report

https://www.thebusinessresearchcompany.com/report/non-small-cell-lung-cancer-nsclc-global-market-report

Non Small Cell Lung Cancer Nsclc Market Report

https://www.thebusinessresearchcompany.com/report/non-small-cell-lung-cancer-nsclc-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Valuation Is Forecasted For The Lung Cancer Surgery Market By 2030 Starting From Its 2026 Size?

The market for lung cancer surgery has demonstrated robust growth over recent years. It is anticipated to expand from $5.33 billion in 2025 to $5.6 billion in 2026, indicating a compound annual growth rate (CAGR) of 5.1%. Historically, this expansion has been propelled by several factors, including escalating lung cancer incidence rates, the broadening of hospital surgical capabilities, the availability of proficient thoracic surgeons, the increasing embrace of video-assisted thoracoscopic surgery, and heightened awareness regarding early-stage lung cancer treatment.

The lung cancer surgery market is projected to experience consistent expansion over the coming years, with its value set to reach $6.73 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 4.7%. This anticipated growth is primarily driven by factors such as the greater integration of robotic surgery platforms, a heightened need for precise surgical results, the proliferation of specialized cancer treatment facilities, increased capital allocation towards surgical innovations, and the wider implementation of enhanced recovery protocols following surgery. Key trends expected during this forecast period encompass the growing adoption of minimally invasive surgical approaches, an uptick in robotic-assisted thoracic surgery, a developing preference for procedures that preserve lung tissue, the expanded use of sophisticated surgical instruments, and an increased emphasis on improving post-operative recovery results.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25816&type=smp

What Major Growth Drivers Are Shaping The Outlook Of The Lung Cancer Surgery Market?

The rising occurrence of lung cancer is anticipated to drive the expansion of the lung cancer surgery market in the foreseeable future. This condition involves the unchecked proliferation of aberrant cells within one or both lungs, disrupting their natural functioning. The elevated incidence of lung cancer stems from extended exposure to air pollution and fine particulate matter; these minute particles can infiltrate deeply into the lungs, resulting in inflammation, cellular harm, and genetic mutations that may trigger cancer formation. Lung cancer surgery plays a crucial role in lowering lung cancer-related mortality by facilitating the prompt removal of malignant tumors before they can disseminate or advance. As an illustration, in June 2025, data from the Centers for Disease Control and Prevention, a US-based federal government agency, indicated that in 2023, lung cancer caused 131,584 deaths in the United States, after 218,893 newly reported cases in 2022. Consequently, the escalating number of lung cancer cases is significantly fueling the expansion of the lung cancer surgery market.

Which Segment Categories Define The Lung Cancer Surgery Market?

The lung cancer surgery market covered in this report is segmented –

1) By Surgical Approach: Thoracotomy, Minimally Invasive Surgeries

2) By Procedure: Lobectomy, Segmentectomy, Pneumonectomy, Sleeve Resection, Extended Reserction

3) By Product: Thoracoscopes, Mediastinoscopes, Bronchoscopes, Robotic-Assistes Thoracic Surgery Systems, Surgical Staplers, Surgical Energy Instruments, Advanced Energy Instruments, Advanced Bipolar Instruments, Ultrasonic Instruments

4) By Distribution Channels: Direct Tender, Retail Sales, Online Sales, Other Channels

5) By End User: Hospitals, Ambulatory And Surgical Centres, Academic And Research Institutes, Specialiaty Cancer Care Centre, Other End Users

Subsegments:

1) By Thoracotomy: Lobectomy, Pneumonectomy, Segmentectomy, Wedge Resection

2) By Minimally Invasive Surgeries: Video-Assisted Thoracoscopic Surgery (VATS), Robotic-Assisted Surgery

Which Trends Are Impacting The Growth Of The Lung Cancer Surgery Market?

Leading companies active in the lung cancer surgery market are concentrating on developing pioneering technologies, such as robotic-assisted operations, to elevate surgical precision, decrease recovery periods, and improve patient results. Robotic-assisted surgeries denote minimally invasive procedures executed with robotic systems guided by surgeons to heighten accuracy, mitigate complications, and enhance patient recovery outcomes. For example, in March 2025, Johnson & Johnson MedTech, a US-based medical devices and technology company, declared the regulatory clearance of MONARCH QUEST under U.S. 510(k). The MONARCH QUEST robotic-assisted bronchoscopy platform offers superior reach and stability to access small, hard-to-reach lung nodules, enhancing the capacity to diagnose lung cancer at earlier stages. Its advanced maneuverability and integration with imaging technologies enable more accurate biopsies while minimizing patient discomfort. Designed to expand procedural capabilities and streamline workflow, the platform fosters greater clinical confidence and consistency across an extensive range of bronchoscopic procedures.

Who Are The Top Companies Competing In The Lung Cancer Surgery Market?

Major companies operating in the lung cancer surgery market are Johnson And Johnson, Medtronic plc, Fujifilm Holdings Corporation, B Braun Melsungen AG, Olympus Corporation, Intuitive Surgical Inc, Teleflex Incorporated, Karl Storz SE, Lepu Medical Technology Beijing Co Ltd, Ambu AS, KLS Martin Group, Richard Wolf GmbH, Ethicon Inc, Ackermann Instrument GmbH, Scanlan International Inc, Sontec Instruments Inc, Covidien LLC, Stryker Corporation, Smith And Nephew plc, CONMED Corporation, Erbe Elektromedizin GmbH

Read the full lung cancer surgery market report here:

https://www.thebusinessresearchcompany.com/report/lung-cancer-surgery-global-market-report

Which Regions Are Projected To Dominate The Lung Cancer Surgery Market In The Coming Years?

North America was the largest region in the lung cancer surgery market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lung cancer surgery market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Lung Cancer Surgery Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=25816&type=smp

Browse Through More Reports Similar to the Global Lung Cancer Surgery Market 2026, By The Business Research Company

Lung Cancer Diagnostic And Screening Global Market Report

https://www.thebusinessresearchcompany.com/report/lung-cancer-diagnostic-and-screening-global-market-report

Non Small Cell Lung Cancer Nsclc Global Market Report

https://www.thebusinessresearchcompany.com/report/non-small-cell-lung-cancer-nsclc-global-market-report

Non Small Cell Lung Cancer Nsclc Global Market Report

https://www.thebusinessresearchcompany.com/report/non-small-cell-lung-cancer-nsclc-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model